Chikungunya virus (CHIKV), a mosquito-borne alphavirus, causes fever and often debilitating, long-lasting joint pain — and its geographic range continues to expand as the Aedes mosquito vectors that transmit it spread into new regions. With at least 5 million cases reported globally over the past 15 years and outbreaks recurring across Africa, Southeast Asia, and the Americas, CHIKV remains an active focus for arbovirus researchers, diagnostics developers, and public health surveillance programs.
This guide surveys the antibody, protein, and ELISA kit tools available for CHIKV research, including a newly added human IgG ELISA kit for seroprevalence and immune-response studies.
Why CHIKV Research Tools Matter Right Now
CHIKV vaccine development has had a turbulent recent history. Ixchiq, the first FDA-approved chikungunya vaccine, received accelerated approval in November 2023 — but in August 2025, the FDA suspended its biologics license following reports of serious chikungunya-like adverse events, including hospitalizations and deaths, concluding that the vaccine's risks outweighed its confirmed benefits. The manufacturer subsequently withdrew its U.S. license and investigational new drug applications in early 2026, leaving the vaccine unavailable in the United States even as global case counts continue to rise.
What this means for research priorities: With vaccine-based prevention now in flux, well-validated serological and diagnostic tools — ELISA kits for antibody detection, structural protein reagents for assay development, and neutralizing antibodies for functional studies — take on renewed importance for tracking CHIKV exposure, supporting outbreak surveillance, and advancing alternative countermeasures.
New: Anti-CHIKV Human IgG ELISA Kit
abinScience has added a CHIKV Human IgG ELISA Kit (VK572028) to its arbovirus diagnostic toolkit, complementing the existing CHIKV Mouse IgM ELISA Kit (VK572018). Together, these kits support both human seroprevalence studies — detecting past exposure via IgG — and mouse model studies of acute infection, where IgM response kinetics are commonly tracked.
CHIKV Research Reagents at a Glance
| Catalog No. |
Product |
Use Case |
| VK572028 |
Anti-CHIKV Human IgG ELISA Kit |
Human seroprevalence / past exposure detection |
| VK572018 |
Anti-CHIKV Mouse IgM ELISA Kit |
Mouse model acute infection response tracking |
| VK572013 |
Anti-CHIKV Spike Glycoprotein E2 Recombinant Antibody (CHK265) |
Neutralizing antibody for E2-targeted functional studies |
| VK425010 |
InVivoMAb Anti-Chikungunya Virus/CHIKV VLP Antibody (m242) |
In vivo neutralization / preclinical challenge studies |
| VK572011 |
CHIKV Spike Glycoprotein E2 Recombinant Protein (C-Fc) |
ELISA standard / antibody validation |
| VK425011 |
CHIKV Spike Glycoprotein E1 Recombinant Protein (C-Fc) |
Fusion-mechanism and structural studies |
| VK640012 |
CHIKV NSP2 Recombinant Protein (N-GST-His) |
Non-structural protein target for antiviral/protease research |
abinScience's CHIKV catalog also includes structural polyprotein antibodies (p130), capsid protein reagents, and additional non-structural protein targets (NSP1, NSP3, NSP4) for teams studying viral replication mechanisms. Browse the full CHIKV research reagent catalog →
Choosing the Right CHIKV Tool for Your Study
Seroprevalence or diagnostic studies: Start with the IgG or IgM ELISA kits to detect human or animal antibody responses to prior or acute CHIKV exposure.
Structural biology or vaccine antigen work: Use E1/E2 glycoprotein recombinant proteins as standards or immunogens; these surface glycoproteins remain the primary target for neutralizing antibody responses.
In vivo challenge or neutralization studies: The InVivoMAb-grade antibody is formulated azide-free for use in animal models evaluating antibody-mediated protection.
Replication and antiviral mechanism studies: Non-structural protein reagents (NSP1–NSP4) support work on the viral replication complex, relevant to antiviral drug discovery independent of vaccine development.
Studying Chikungunya Virus?
abinScience offers antibodies, recombinant proteins, and ELISA kits covering CHIKV structural and non-structural targets, including the newly added Human IgG ELISA Kit for seroprevalence research. Browse the full catalog → or contact our technical team at support@abinscience.com for assay-specific recommendations.
中文
English
한국어
日本語
Español
Français
Русский
